Phebe N Novakovic General Dynamics Corp (GD) insider trading activity

Phebe N Novakovic is Chairman and CEO of GENERAL DYNAMICS CORP. Currently has a direct ownership of 769,607 shares of GD, which is worth approximately $209 Million. The most recent transaction as insider was on Mar 05, 2025, when has been sold 32,695 shares (Common Stock) at a price of $263.48 per share, resulting in proceeds of $8,614,478. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 770K

0.08% 3M change

6.01% 12M change

Total Value Held $209 Million

PHEBE N NOVAKOVIC Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Mar 05 2025	SELL Open market or private sale	$8,614,478 $263.48 p/Share	32,695 Reduced 4.08%	769,607 Common Stock
Mar 05 2025	BUY Grant, award, or other acquisition	-	13,510 Added 1.66%	802,302 Common Stock
Mar 04 2025	SELL Payment of exercise price or tax liability	$5,345,901 $253.95 p/Share	21,051 Reduced 2.6%	788,792 Common Stock
Mar 04 2025	BUY Grant, award, or other acquisition	-	46,675 Added 5.45%	809,843 Common Stock
Mar 03 2025	SELL Payment of exercise price or tax liability	$1,476,124 $254.11 p/Share	5,809 Reduced 0.76%	763,168 Common Stock
Apr 26 2024	SELL Open market or private sale	$14,179,832 $284.45 p/Share	49,850 Reduced 6.09%	768,977 Common Stock
Mar 06 2024	BUY Grant, award, or other acquisition	-	12,205 Added 1.47%	818,827 Common Stock
Mar 05 2024	SELL Payment of exercise price or tax liability	$9,125,087 $274.91 p/Share	33,193 Reduced 3.95%	806,622 Common Stock
Mar 05 2024	BUY Grant, award, or other acquisition	-	73,598 Added 8.06%	839,815 Common Stock
Mar 04 2024	SELL Payment of exercise price or tax liability	$2,121,351 $273.37 p/Share	7,760 Reduced 1.0%	766,217 Common Stock
Jan 29 2024	SELL Open market or private sale	$8,563,397 $264.67 p/Share	32,355 Reduced 4.01%	773,977 Common Stock
Jan 26 2024	SELL Payment of exercise price or tax liability	$47,634,295 $265.72 p/Share	179,265 Reduced 18.19%	806,332 Common Stock
Jan 26 2024	BUY Exercise of conversion of derivative security	$40,569,670 $191.71 p/Share	211,620 Added 17.68%	985,597 Common Stock
Oct 27 2023	SELL Bona fide gift	-	4,115 Reduced 0.53%	773,977 Common Stock
Aug 11 2023	SELL Open market or private sale	$7,572,452 $227.88 p/Share	33,230 Reduced 4.1%	778,092 Common Stock
Mar 08 2023	BUY Grant, award, or other acquisition	-	13,620 Added 1.65%	811,322 Common Stock
Mar 07 2023	SELL Payment of exercise price or tax liability	$4,585,890 $231.88 p/Share	19,777 Reduced 2.42%	797,702 Common Stock
Mar 07 2023	BUY Grant, award, or other acquisition	-	43,850 Added 5.09%	817,479 Common Stock
Mar 06 2023	SELL Payment of exercise price or tax liability	$1,745,110 $231.97 p/Share	7,523 Reduced 0.96%	773,629 Common Stock
Aug 09 2022	SELL Open market or private sale	$16,254,520 $227.46 p/Share	71,461 Reduced 8.38%	781,152 Common Stock
Aug 08 2022	SELL Payment of exercise price or tax liability	$56,942,626 $228.87 p/Share	248,799 Reduced 22.59%	852,613 Common Stock
Aug 08 2022	BUY Exercise of conversion of derivative security	$43,507,323 $135.85 p/Share	320,260 Added 22.53%	1,101,412 Common Stock
Mar 07 2022	SELL Payment of exercise price or tax liability	$1,681,613 $250.24 p/Share	6,720 Reduced 0.85%	781,152 Common Stock
Mar 02 2022	BUY Grant, award, or other acquisition	-	12,880 Added 1.61%	787,872 Common Stock
Mar 01 2022	SELL Payment of exercise price or tax liability	$49,224,934 $234.03 p/Share	210,336 Reduced 21.35%	774,992 Common Stock

Also insider at

ABT

ABBOTT LABORATORIES Healthcare

JPM

JPMORGAN CHASE & CO Financial Services

Director

PNN